1. A multicenter comparison of isradipine and prazosin for treatment of essential hypertension

   • Stephen L. Swartz
   • Leonard M. Gonasun
   • Udho Thadani

   Clinical Trials Pages: 413 - 417

2. A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure

   • OPC-8212 Multicenter Research Group
   • Shigetake Sasayama

   Clinical Trials Pages: 419 - 425

3. Left ventricular hypertrophy reversal with labetalol and propranolol: A prospective, randomized, double-blind study

   • Jadwiga Szlachcic
   • W. Dallas Hall
   • Barry Massie

   Clinical Trials Pages: 427 - 433

4. Twenty-four hour ambulatory blood pressure profile of a new, sustained-release preparation of nicardipine

   • Paul A. Broadhurst
   • Geoffrey Brigden
   • Edward B. Raftery

   New Calcium Antagonists Pages: 435 - 438

5. Twenty-four hour profile of the hypotensive action of felodipine in essential hypertension

   • Ian G. Crozier
   • Hamid Ikram
   • Clive J. S. Low

   New Calcium Antagonists Pages: 439 - 442

6. Felodipine prevents the poststenotic myocardial ischemia induced by alpha₂-adrenergic coronary constriction

   • Thomas Ehring
   • Gerd Heusch

   New Calcium Antagonists Pages: 443 - 449

7. Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol

   • Terje R. Pedersen
   • Michael Kantor

   New Calcium Antagonists Pages: 451 - 456

8. An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease

   • Bernard Silke
   • E. Goldhammer
   • Stanley H. Taylor

   Ischemic Heart Disease Pages: 457 - 463

9. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs

   • Gary J. Grover
   • Steven Dzwonczyk
   • Paul G. Sleph

   Ischemic Heart Disease Pages: 465 - 474

10. Hemodynamic and coronary vasodilative action of two nitroglycerin oral spray formulations

    • Rolf E. Gansser
    • Adam Schneeweiss
    • Kurt F. Bachmann

    Ischemic Heart Disease Pages: 475 - 480

11. Propionyl carnitine in stable effort angina

    • Angelo Cherchi
    • Carlo Lai
    • Marco Corsi

    Ischemic Heart Disease Pages: 481 - 486

12. Interaction of tertatolol with rifampicin and ranitidine pharmacokinetics and antihypertensive activity

    • W. Kirch
    • S. Milferstädt
    • L. Jung

    Pharmacokinetics Pages: 487 - 491

13. Relationship between age and the cardiovascular response to meals

    • Timothy C. Fagan
    • Kenneth A. Conrad
    • Mary J. Mackie

    Pharmacokinetics Pages: 493 - 497

14. Effects of nifedipine versus hydralazine on sympathetic activity and cardiac function in patients with hypertension persisting on diuretic plus beta-blocker therapy

    • Frans H. H. Leenen
    • Martin G. Myers
    • David Frankel

    Pharmacokinetics Pages: 499 - 504

15. Atenolol in dilated cardiomyopathy: A clinical instrumental study

    • A. V. Mattioli
    • M. G. Modena
    • G. Mattioli

    Congestive Heart Failure Pages: 505 - 507

16. Involvement of purine compounds in the inotropic action of milrinone

    • P. Dorigo
    • R. M. Gaion
    • I. Maragno

    Congestive Heart Failure Pages: 509 - 513

17. Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure—A placebo-controlled trial

    • W. Haerer
    • U. Bauer
    • V. Hombach

    Congestive Heart Failure Pages: 515 - 521

18. Electrophysiologic effects of intravenous xamoterol in patients with sinus node dysfunction

    • M. de Marneffe
    • P. Waterschoot
    • M. Englert

    Arrhythmias Pages: 523 - 527

19. Stability of plasma amiodarone levels during chronic oral therapy

    • Killian Robinson
    • Atholl Johnston
    • William McKenna

    Arrhythmias Pages: 529 - 530